Endeavour Vision

News! We are pleased to announce that we have signed a definitive agreement to acquire Gynesonics, a developer of minimally invasive solutions for women’s health. Read more here: https://ow.ly/NJzZ50TKO3Y.

Join us in welcoming Matthew Levesque as our new Chief Executive Officer and a member of our Board of Directors! Matt brings nearly three decades of healthcare IT and two-sided marketplace experience to IntelyCare - all rooted in delivering the highest level of care. "It's time to bring IntelyCare's expertise to more nurses in more diverse care settings. Our goal is not just to fill shifts. We are committed to providing a total talent solution that promotes quality care and nursing career development, while simultaneously meeting our partner clients’ unique staffing and hiring needs." - Matthew Levesque Welcome to the IntelyCare family, Matt! Read the full announcement below.

🔊 Excited to announce the CeQur Simplicity® wearable insulin patch obtains FDA-Clearance for 4-days of wear to further simplify diabetes management. Read here: https://lnkd.in/enYhscEh #CeQurSimplicity #InsulinPatch #MealtimeInsulin #Diabetes

Yesterday, I had the pleasure of participating in a panel discussion on late-stage investment in the medical device sector. The session, moderated by David Cassak from MedTech Strategist, gave us insights into funding strategies for startups approaching late-stage funding.   My key takeaways: → Commercialization is key Securing initial approvals and demonstrating market readiness is crucial for attracting serious late-stage investments, particularly with the focus of M&A activities on commercially viable entities. → Build early investor relationships Engaging early and consistently with potential late-stage investors significantly increases your chances of securing investment when it matters most. → Stay resilient The investment landscape is cyclical and demanding. Startups need to remain resilient and adaptable through fluctuating market conditions. → Focus on clinical needs over technology The primary driver for investment should be the potential to meet unmet clinical needs, not just technological innovation. → Prepare for in-depth evaluations Startups at this stage need to be prepared to show their product's capabilities, solid business models, clear regulatory pathways, and effective commercial strategies. → Engage with the market early Showing early market traction is key. Investors want to see that startups can do both: enter the market and effectively expand their share. These insights are valuable for any med tech startup dealing with the complex waters of late-stage funding. Yes, the path to securing necessary capital at this stage is complex but understanding these principles can significantly enhance a startup’s strategy to scale and succeed. #medtech #investmentstrategies #startupfunding #innovationsummitdublin #medtechinnovator

The ABCs of #LSIUSA24 — Today’s letter of the day is ‘W’. Here are the 3 Panels from LSI USA ‘24 that start with the letter ‘W’: What Does 2024 Hold For the Frozen IPO Market? • Kimberly Ha (Moderator) — KKH Advisors • M. Jaione Maiz, PhD, MBA— Anzu Partners • Eric J. Dimise, PhD — NYSE • Shayne Kennedy — Latham & Watkins Why is Women's Health Still an Under-Ventured Market? • Holly Scott (Moderator) — The Mullings Group • Tara Ghazi, Ph.D. — MALCOVA • Terri Burke — Epidarex Capital • Todd Usen — Minerva Surgical, Inc. • Amrish Nair — Biorithm Why the Heck Can’t I Raise Capital • Nick Pachuda (Moderator) — Precision Life Sciences • Tamir Meiri — Johnson & Johnson Innovation • Deanna Harshbarger — Cala Health • Kevin Rocco — CONMED Corporation • Jeffrey O'Donnell, Jr. Sr. — Runway Healthcare L.P. • Fernando Pacheco — Endeavour Vision The full video recording of ‘Why is Women's Health Still an Under-Ventured Market?’, is available now on our website and YouTube channel. The remaining panels will be made available in the coming weeks. Want to see more content like this? Join us at LSI Europe ‘24 this September 16th - 20th in Portugal. Secure your spot today, to ensure you get the best rate and secure a hotel room onsite at the Penha Longa Resort.

Today we announced closing of $20 million #financing to support commercial expansion and clinical activities for the BEAR Implant, which has been used to treat nearly 3,000 patients with #ACLtears. We're excited to welcome The MLS Players Association, SV Health Investors and Aperture Venture Partners. Learn more below. #ACLrestoration #savetheACL #funding #medtech Endeavour Vision Silicon Valley Bank dsm-firmenich Venturing NFL Players Association

📺 Panda News Alert: New Partner 📺    We are excited to share that Lumeon has joined the Panda Health Platform as a part of the #CareOrchestration category!    With Lumeon, care teams can eliminate waste and create time to care, deliver best practices at scale, and transform #patient experiences.      Lumeon unlocks the potential of care teams with clinical workflow automation that:   ✅ Automates tasks, workflow, and activities   ✅ Integrates seamlessly with EHR and other systems   ✅ Boosts care team capacity and efficiency   ✅ Cuts costs and improves margins   ✅ Delivers consistent, quality outcomes     “Wading through the barrage of digital health solutions can be overwhelming for hospitals and health systems,” said Cindy Gaines, Chief Clinical Transformation Officer at Lumeon. “Being designated as a Panda Partner allows health systems to feel more confident that Lumeon’s clinical workflow automation solutions can meet their toughest care delivery challenges.” #digitalhealthpartner #digitalhealth #automation #patientcare #carecoordination #pandahealth